UNSPSC 51111663: Valopicitabine

This classification denotes a pyrimidine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I2T0B5G94M. European Medicines Agency schedules Valopicitabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB35614. Valopicitabine generally arises in the molecular formula C15H24N4O6.

UNSPSC 51111663 Valopicitabine is a Commodity code for an antiviral pharmaceutical with limited recent state and local procurement activity. The code designates a specific drug substance used in treating viral infections; state and local health departments and institutional healthcare facilities would procure this medication through pharmacy purchasing channels, typically as part of formulary acquisitions or episodic treatment protocols. When purchased, valopicitabine appears alongside other antivirals in bulk or unit-dose contracts managed by state pharmaceutical programs, county health systems, or municipal hospital networks rather than as a standalone line item.

No recent state and local contract opportunities appear in the available records under this code. The absence of posted RFPs, RFQs, IFBs, or ITBs suggests either minimal current demand, direct procurement through existing state pharmaceutical contracts or group purchasing organizations, or issuing bodies tagging such acquisitions under broader pharmaceutical or pharmacy-supply codes rather than this specific substance designation. Without active solicitation history, the code does not signal current market opportunity for vendors in this space.